IL9
Interleukin-9
Also known as: HP40, IL-9, IL9_HUMAN, P40
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15248
- Gene
- IL9
- Ensembl
- ENSG00000145839
- Chromosome
- 5
- Canonical length
- 144 aa
- Protein class
- Cancer-related genes, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a cytokine that acts as a regulator of a variety of hematopoietic cells. This cytokine stimulates cell proliferation and prevents apoptosis. It functions through the interleukin 9 receptor (IL9R), which activates different signal transducer and activator (STAT) proteins and thus connects this cytokine to various biological processes. The gene encoding this cytokine has been identified as a candidate gene for asthma. Genetic studies on a mouse model of asthma demonstrated that this cytokine is a determining factor in the pathogenesis of bronchial hyperresponsiveness. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
144 residues, UniProt reviewed canonical sequence.
>P15248|IL9
1 MLLAMVLTSA LLLCSVAGQG CPTLAGILDI NFLINKMQED PASKCHCSAN VTSCLCLGIP
61 SDNCTRPCFS ERLSQMTNTT MQTRYPLIFS RVKKSVEVLK NNKCPYFSCE QPCNQTTAGN
121 ALTFLKSLLE IFQKEKMRGM RGKILocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 0.9 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 0.9 nTPM
- skin: 0.4 nTPM
- thymus: 0.2 nTPM
- esophagus: 0.1 nTPM
- salivary gland: 0.1 nTPM
- adipose tissue: 0 nTPM
Single-cell type
- platelets: 1.4 nCPM
- late primary spermatocytes: 0.2 nCPM
- early spermatids: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 2.5 nTPM
- hypothalamus: 2.3 nTPM
- cerebral cortex: 2.2 nTPM
- midbrain: 1.9 nTPM
- thalamus: 1.9 nTPM
- medulla oblongata: 1.8 nTPM
ReferencesPubMed · IEDB
Publications for IL9 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice.
2000 · Proc Natl Acad Sci U S A · RCR 2.4 · 130 citations - Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
2015 · Mol Med · RCR 1.3 · 44 citations - IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
2005 · J Immunol · RCR 1.1 · 51 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.25
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell differentiation
- B cell proliferation
- immunoglobulin mediated immune response
- inflammatory response
- interleukin-9-mediated signaling pathway
- positive regulation of cell growth
- positive regulation of cell population proliferation
- positive regulation of interleukin-5 production
- regulation of receptor signaling pathway via JAK-STAT
Molecular functions
- cytokine activity
- growth factor activity
- interleukin-9 receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Interleukin-7/Interleukin-9, conserved site
- Interleukin-9
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL9 as an antibody target. Whether an autoantibody or antibody against IL9 could matter depends on whether native IL9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL9 is annotated as secreted, so native IL9 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...